Public Profile

Biocause

Biocause, a leading name in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2010, the company has made significant strides in the development of innovative biopharmaceuticals and diagnostic solutions, focusing on enhancing patient outcomes through advanced research and technology. Specialising in biologics and personalised medicine, Biocause offers a unique portfolio of products that stand out for their efficacy and safety. The company has achieved notable milestones, including several successful clinical trials and partnerships with major healthcare institutions, solidifying its position as a key player in the industry. With a commitment to scientific excellence and patient-centric solutions, Biocause continues to drive advancements in healthcare, making a meaningful impact on global health challenges.

DitchCarbon Score

How does Biocause's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Biocause's score of 13 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Biocause's reported carbon emissions

Biocause, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential for Biocause to establish clear climate commitments and reduction strategies to align with industry standards and demonstrate accountability in their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biocause's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Biocause is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biocause is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

Fertiglobe

GB
Chemicals
Updated 11 days ago

Quimica Basica SAS

CO
Chemicals
Updated 11 days ago

Hawk ChemicalLLC

US
Chemicals
Updated 11 days ago

Norex

SE
Chemicals
Updated 3 days ago

Xcene Research

NG
Chemicals
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers